Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00467025
Recruitment Status : Completed
First Posted : April 27, 2007
Last Update Posted : March 23, 2016
Sponsor:
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2010
Actual Study Completion Date : June 2014
Certification/Extension First Submitted : April 6, 2015